Transcutaneous Photodynamic Therapy Alters the Development of an Adoptively Transferred Form of Murine Experimental Autoimmune Encephalomyelitis
暂无分享,去创建一个
[1] C. Elmets,et al. Inhibition of the high affinity Fc receptor (Fc gamma RI) on human monocytes by porphyrin photosensitization is highly specific and mediated by the generation of superoxide radicals. , 1989, The Journal of biological chemistry.
[2] R. Straight,et al. SYSTEMIC IMMUNOSUPPRESSION INDUCED BY PHOTODYNAMIC THERAPY (PDT) IS ADOPTIVELY TRANSFERRED BY MACROPHAGES , 1989, Photochemistry and photobiology.
[3] M. Waldor,et al. Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. , 1985, Science.
[4] B. Arnason. Interferon beta in multiple sclerosis , 1993, Neurology.
[5] B. Beutler,et al. The biology of cachectin/TNF--a primary mediator of the host response. , 1989, Annual review of immunology.
[6] C. Elmets,et al. Immunological suppression in mice treated with hematoporphyrin derivative photoradiation. , 1986, Cancer research.
[7] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[8] R. McCarron,et al. Adoptively transferred experimental autoimmune encephalomyelitis in SJL/J, PL/J, and (SJL/J x PL/J)F1 mice. Influence of I-A haplotype on encephalitogenic epitope of myelin basic protein. , 1988, Journal of Immunology.
[9] R. Fiel,et al. CUTANEOUS PHOTOSENSITIZING AND IMMUNOSUPPRESSIVE EFFECTS OF A SERIES OF TUMOR LOCALIZING PORPHYRINS , 1991, Photochemistry and photobiology.
[10] J. Levy,et al. Photofrin, but not benzoporphyrin derivative, stimulates hematopoiesis in the mouse. , 1993, Immunopharmacology.
[11] Richard G Richards. Interferon beta in multiple sclerosis , 1996, BMJ.
[12] T J Dougherty,et al. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.
[13] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[14] A. Richter,et al. Efficacy of benzoporphyrin derivative, a photosensitizer, in selective destruction of leukemia cells using a murine tumor model. , 1993, Experimental hematology.
[15] J. Rothbard,et al. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[16] M. Obochi,et al. ACTIVATION OF BENZOPORPHYRIN DERIVATIVE IN THE CIRCULATION OF MICE WITHOUT SKIN PHOTOSENSITIVITY , 1994, Photochemistry and photobiology.
[17] J D Waterfield,et al. The use of transcutaneous photodynamic therapy in the prevention of adjuvant-enhanced arthritis in MRL/lpr mice. , 1994, Clinical immunology and immunopathology.
[18] D. McFarlin,et al. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. , 1983, Journal of immunology.
[19] D. Mason,et al. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. , 1984, Journal of immunology.
[20] H. Mcdevitt,et al. T cell receptors in murine autoimmune diseases. , 1989, Annual review of immunology.
[21] L. Steinman,et al. The T lymphocyte in experimental allergic encephalomyelitis. , 1990, Annual review of immunology.
[22] W. Hickey,et al. T‐lymphocyte entry into the central nervous system , 1991, Journal of neuroscience research.
[23] W. F. Wright,et al. In vitro cellular effects of hematoporphyrin derivative. , 1982, Cancer research.
[24] A. Hornby,et al. Relative sensitivity of leukemic (CML) and normal progenitor cells to treatment with the photosensitizer benzoporphyrin derivative and light. , 1993, Journal of hematotherapy.
[25] R. McCarron,et al. Adoptively transferred acute and chronic relapsing autoimmune encephalomyelitis in the PL/J mouse and observations on altered pathology by intercurrent virus infection. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[26] R. von Baehr,et al. Inhibition of HLA-DR antigen expression and of the allogeneic mixed leukocyte reaction by photochemical treatment. , 2008, Tissue antigens.
[27] R. Hohlfeld,et al. T-cell autoimmunity in multiple sclerosis. , 1995, Immunology today.
[28] C. Pettinelli,et al. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. , 1981, Journal of immunology.
[29] S. B. Brown,et al. Photodynamic therapy--achievements and prospects. , 1989, British Journal of Cancer.
[30] MOUSE SKIN PHOTOSENSITIZATION WITH BENZOPORPHYRIN DERIVATIVES AND PHOTOFRIN®: MACROSCOPIC AND MICROSCOPIC EVALUATION , 1991, Photochemistry and photobiology.
[31] C. Dahle,et al. Isolating RNA from whole blood — the dawn of RNA-based diagnosis? , 1993, Nature.
[32] J D Waterfield,et al. Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant‐enhanced arthritis in MRL‐lpr mice , 1994, Clinical and experimental immunology.
[33] L. Hood,et al. The T-cell receptor repertoire and autoimmune diseases. , 1989, Annual review of immunology.
[34] A. Jain,et al. TARGETING ACTIVATED LYMPHOCYTES WITH PHOTODYNAMIC THERAPY: SUSCEPTIBILITY OF MITOGEN‐STIMULATED SPLENIC LYMPHOCYTES TO BENZOPORPHYRIN DERIVATIVE (BPD) PHOTOSENSITIZATION , 1995, Photochemistry and photobiology.
[35] H. Mcdevitt,et al. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention , 1988, Cell.
[36] L. Hood,et al. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy , 1988, Cell.
[37] J. Newcombe,et al. The nature of inflammatory components during demyelination in multiple sclerosis , 1988, Journal of Neuroimmunology.
[38] D. Dolphin,et al. Preliminary studies on a more effective phototoxic agent than hematoporphyrin. , 1987, Journal of the National Cancer Institute.
[39] D. Dolphin,et al. Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice. , 1990, Journal of photochemistry and photobiology. B, Biology.
[40] R. Knobler,et al. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination , 1985, Nature.
[41] C. Pettinelli,et al. Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. , 1982, Journal of immunology.
[42] C J Gomer,et al. Molecular, cellular, and tissue responses following photodynamic therapy , 1988, Lasers in surgery and medicine.
[43] J. Levy,et al. Photosensitizers as virucidal agents. , 1993, Journal of photochemistry and photobiology. B, Biology.